New online customer portal for custom research services

14 May 2018

Customers to gain a greater insight into their projects, better track project progress and improve communications.

Oxford Genetics has launched a new online customer portal designed to enable customers to better monitor project progress and track communications.

New online customer portal for custom research services

This new portal provides customers with real-time updates through 24/7 access to the status of the projects they have underway with Oxford Genetics. The system collates project information from several sources, including bespoke Enterprise Resource Planning (ERP) systems and Laboratory Information Management (LIM) systems, to produce live Gannt charts.

It also gives immediate access to all supporting documentation, such as order history, quality assurance/quality control (QA/QC) reports, and project progress reports.

Ryan Cawood, CEO of Oxford Genetics said: “The primary reason for developing the tool was that by automating data collection and dissemination many of the traditional bottlenecks of managing projects by manual methods can be eliminated.

"The launch of this portal shows our commitment to providing a more valuable and simplified online environment for our customers. We are focused on delivering both innovative technologies and exceptional service, and the deployment of this online portal helps us enhance the overall experience our customers have with us. By providing customers with visibility of their projects, they can now choose how and when to interact with our team, streamlining their user experience and allowing Oxford Genetics to be more flexible and personally responsive to each customer.

“Added to this, the growth trajectory of Oxford Genetics fed the need to improve efficiencies and streamline operations to allow the company to continue providing a high quality-service to its customers. By implementing this tool across our customer projects, we can use resources more effectively and benefit from a scalable architecture that can support hundreds of concurrent projects.”

The portal has taken around 12 months to build and was extensively tested with key customers to ensure it met the needs of all users.

Adam Marsden, Head of Informatics, Oxford Genetics said: “This new feature puts the power into the hands of our customers. No competitors in our industry have the level of laboratory automation, IT resources and back-end infrastructure to support an online portal like this."

Read More

Related news

Allergan to establish R&D presence in Cambridge, Massachusetts

Allergan to establish R&D presence in Cambridge, Massachusetts

10 Jan 2019

The new, strategic presence will allow the company to more easily interact and engage with venture firms and start ups in the area.

Read more 
Expedeon signs supply and license agreement for is Lightning-Link technology

Expedeon signs supply and license agreement for is Lightning-Link technology

9 Jan 2019

The technology will enable Cell Guidance Systems to manufacture TRIFic detection assays on-demand with highly reproducible and scalable results.

Read more 
WuXi AppTec expands site in California for pharmaceutical R&D services

WuXi AppTec expands site in California for pharmaceutical R&D services

13 Dec 2018

Expanded facility will establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D including Phase I GMP manufacturing.

Read more 
Cambrex expands analytical capabilities

Cambrex expands analytical capabilities

12 Dec 2018

The $1 million investment will assist in getting new products to commercial launch faster.

Read more 
MIT engineers repurpose wasp venom as an antibiotic drug

MIT engineers repurpose wasp venom as an antibiotic drug

9 Dec 2018

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

Read more 
Spanish CDMO working ahead of EU serialisation deadline

Spanish CDMO working ahead of EU serialisation deadline

6 Dec 2018

Company now able to serialise commercial batches manufactured by them for clients; it can also offer standalone serialisation services as an outsourcing partner.

Read more 
Fluidic Analytics raises $31m to launch new lab tools and unlock biology behind major diseases

Fluidic Analytics raises $31m to launch new lab tools and unlock biology behind major diseases

5 Dec 2018

The financing will power the global commercial launch of the company's Fluidity One system.

Read more 
OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

OnDosis and Recipharm partner to advance a novel treatment regimen for ADHD

4 Dec 2018

The new treatment will leverage OnDosis’ proprietary technology, which integrates oral drugs in form of micro units and individualised dosing, in a handheld device.

Read more 
NIH to evaluate effectiveness of male contraceptive skin gel

NIH to evaluate effectiveness of male contraceptive skin gel

28 Nov 2018

The gel formulation includes the progestin compound segesterone acetate, in combination with testosterone, and is applied to the back and shoulders and absorbed through the skin.

Read more 
QPS expands US-based Phase I clinical trial capabilities

QPS expands US-based Phase I clinical trial capabilities

27 Nov 2018

Expansion supports the growing needs of the company's pharmaceutical, biotechnology and CRO partners.

Read more